Mitral and tricuspid hotline

Anchorperson: M. Adamo
Spokesperson: S. Ludwig
SHOW MORE

Summary

This session provides updates on the latest developments in transcatheter mitral and tricuspid valve interventions. Key topics include one-year outcomes of the MiCLASP study on transcatheter mitral repair, the impact of residual mitral and tricuspid regurgitation after transcatheter repair, and the early feasibility of the AltaValve system. Discussions also cover the outcomes of transcatheter edge-to-edge repair for primary tricuspid regurgitation and the use of the LuxValvePlus system for transcatheter tricuspid valve implantation.

Presentations available when logged in:

  • Transcatheter mitral repair in patients with moderate mitral regurgitation: one-year outcomes from the MiCLASP study
  • Impact of intra-procedural residual mitral regurgitation and gradient following TEER for primary mitral regurgitation
  • Report on the AltaValve early feasibility study
  • One-year outcomes of transcatheter edge-to-edge repair for primary tricuspid regurgitation
  • Impact of residual tricuspid regurgitation after transcatheter tricuspid valve repair on survival
  • Transcatheter tricuspid valve implantation using the LuxValvePlus system: compassionate use outcomes
  • Multivalvular disease in TAVR-patients: Multicentre study on impact of staged valvular interventions